How IDEXX Laboratories (IDXX) Makes Money: A Visual Guide
IDEXX Laboratories (IDXX) generated $4.30B in revenue (TTM through Q4 2025), earning $1.06B in net profit (24.6% margin). Its largest revenue source is Product (59% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.
IDEXX Laboratories (IDXX) Income Statement Flow
Frequently asked questions
How does IDEXX Laboratories (IDXX) make money?
- IDEXX Laboratories (IDXX) primarily makes money through Product, which accounts for 59% of total revenue. For TTM through Q4 2025, IDEXX Laboratories generated $4.30B in total revenue with a net profit margin of 24.6%.
What is IDEXX Laboratories (IDXX) gross profit margin?
- IDEXX Laboratories (IDXX) reported a gross profit margin of 61.8% for TTM through Q4 2025, equivalent to $2.66B in gross profit. This means IDEXX Laboratories retains 61.8% of each revenue unit after direct costs of production.
What is IDEXX Laboratories (IDXX) operating profit margin?
- IDEXX Laboratories (IDXX) reported an operating profit margin of 31.6% for TTM through Q4 2025, equivalent to $1.36B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is IDEXX Laboratories (IDXX) net profit margin?
- IDEXX Laboratories (IDXX) reported a net profit margin of 24.6% for TTM through Q4 2025, equivalent to $1.06B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does IDEXX Laboratories (IDXX) invest in R&D?
- IDEXX Laboratories (IDXX) invested $251.21M in research and development in TTM through Q4 2025 (5.8% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does IDEXX Laboratories (IDXX) spend on capital expenditures?
- IDEXX Laboratories (IDXX) spent $124.68M on capital expenditures in TTM through Q4 2025 (2.9% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is IDEXX Laboratories (IDXX) free cash flow?
- IDEXX Laboratories (IDXX) generated $1.05B in free cash flow for TTM through Q4 2025 (24.5% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is IDEXX Laboratories (IDXX) effective tax rate?
- IDEXX Laboratories (IDXX) had an effective tax rate of 20% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.
About this data
- What is a Sankey diagram?
- A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
- How is the data calculated?
- We use the income statement from company filings. For TTM (Trailing Twelve Months), we sum the last four quarters. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
- When was this data last updated?
- Based on company filings through TTM through Q4 2025.